{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T09:38:14Z","timestamp":1794908294737,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>SARS-CoV-2 enters host cells through an interaction between the spike glycoprotein and the angiotensin converting enzyme 2 (ACE2) receptor. Directly preventing this interaction presents an attractive possibility for suppressing SARS-CoV-2 replication. Here, we report the isolation and characterization of an alpaca-derived single domain antibody fragment, Ty1, that specifically targets the receptor binding domain (RBD) of the SARS-CoV-2 spike, directly preventing ACE2 engagement. Ty1 binds the RBD with high affinity, occluding ACE2. A cryo-electron microscopy structure of the bound complex at 2.9\u2009\u00c5 resolution reveals that Ty1 binds to an epitope on the RBD accessible in both the \u2018up\u2019 and \u2018down\u2019 conformations, sterically hindering RBD-ACE2 binding. While fusion to an Fc domain renders Ty1 extremely potent, Ty1 neutralizes SARS-CoV-2 spike pseudovirus as a 12.8\u2009kDa nanobody, which can be expressed in high quantities in bacteria, presenting opportunities for manufacturing at scale. Ty1 is therefore an excellent candidate as an intervention against COVID-19.<\/jats:p>","DOI":"10.1038\/s41467-020-18174-5","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T06:03:02Z","timestamp":1599199382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":335,"title":["An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-2418","authenticated-orcid":false,"given":"Leo","family":"Hanke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-812X","authenticated-orcid":false,"given":"Laura","family":"Vidakovics Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Sheward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Moliner-Morro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnane","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla B.","family":"Karlsson Hedestam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6781-0345","authenticated-orcid":false,"given":"B. Martin","family":"H\u00e4llberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-4445","authenticated-orcid":false,"given":"Ben","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-7241","authenticated-orcid":false,"given":"Gerald M.","family":"McInerney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"18174_CR1","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Cell entry mechanisms of SARS-CoV-2. Proc. Natl Acad. Sci. USA 117, 11727\u201311734 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18174_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"18174_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e286 (2020).","journal-title":"Cell"},{"key":"18174_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell 182, 73\u201384 e16 (2020).","journal-title":"Cell"},{"key":"18174_CR5","doi-asserted-by":"crossref","unstructured":"Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115\u2013119 (2020).","DOI":"10.1038\/s41586-020-2380-z"},{"key":"18174_CR6","doi-asserted-by":"crossref","unstructured":"Shi, R. et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120\u2013124 (2020).","DOI":"10.1038\/s41586-020-2381-y"},{"key":"18174_CR7","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","volume":"8","author":"P Bannas","year":"2017","unstructured":"Bannas, P., Hambach, J. & Koch-Nolte, F. Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics. Front. Immunol. 8, 1603 (2017).","journal-title":"Front. Immunol."},{"key":"18174_CR8","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1074\/jbc.M806889200","volume":"284","author":"C Vincke","year":"2009","unstructured":"Vincke, C. et al. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J. Biol. Chem. 284, 3273\u20133284 (2009).","journal-title":"J. Biol. Chem."},{"key":"18174_CR9","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1128\/JVI.03178-13","volume":"88","author":"FM Cardoso","year":"2014","unstructured":"Cardoso, F. M. et al. Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge. J. Virol. 88, 8278\u20138296 (2014).","journal-title":"J. Virol."},{"key":"18174_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.01802-15","volume":"60","author":"L Detalle","year":"2016","unstructured":"Detalle, L. et al. Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection. Antimicrob. Agents Chemother. 60, 6\u201313 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"18174_CR11","doi-asserted-by":"crossref","unstructured":"Hanke, L. et al. The antiviral mechanism of an influenza a virus nucleoprotein-specific single-domain antibody fragment. mBio 7, e01569\u201316 (2016).","DOI":"10.1128\/mBio.01569-16"},{"key":"18174_CR12","doi-asserted-by":"publisher","first-page":"11577","DOI":"10.1021\/la801186w","volume":"24","author":"II Gorshkova","year":"2008","unstructured":"Gorshkova, I. I., Svitel, J., Razjouyan, F. & Schuck, P. Bayesian analysis of heterogeneity in the distribution of binding properties of immobilized surface sites. Langmuir 24, 11577\u201311586 (2008).","journal-title":"Langmuir"},{"key":"18174_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-60761-670-2_2","volume":"627","author":"P Schuck","year":"2010","unstructured":"Schuck, P. & Zhao, H. The role of mass transport limitation and surface heterogeneity in the biophysical characterization of macromolecular binding processes by SPR biosensing. Methods Mol. Biol. 627, 15\u201354 (2010).","journal-title":"Methods Mol. Biol."},{"key":"18174_CR14","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1016\/S0006-3495(03)75132-7","volume":"84","author":"J Svitel","year":"2003","unstructured":"Svitel, J., Balbo, A., Mariuzza, R. A., Gonzales, N. R. & Schuck, P. Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria. Biophys. J. 84, 4062\u20134077 (2003).","journal-title":"Biophys. J."},{"key":"18174_CR15","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1091\/mbc.e10-08-0683","volume":"21","author":"TD Pollard","year":"2010","unstructured":"Pollard, T. D. A guide to simple and informative binding assays. Mol. Biol. Cell 21, 4061\u20134067 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"18174_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ab.2008.03.035","volume":"377","author":"Y Abdiche","year":"2008","unstructured":"Abdiche, Y., Malashock, D., Pinkerton, A. & Pons, J. Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. Anal. Biochem. 377, 209\u2013217 (2008).","journal-title":"Anal. Biochem."},{"key":"18174_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ab.2017.08.002","volume":"536","author":"V Kamat","year":"2017","unstructured":"Kamat, V. & Rafique, A. Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions. Anal. Biochem. 536, 16\u201331 (2017).","journal-title":"Anal. Biochem."},{"key":"18174_CR18","doi-asserted-by":"crossref","unstructured":"Velazquez-Campoy, A., Leavitt, S. A. & Freire E. Characterization of protein\u2013protein interactions by isothermal titration calorimetry. Methods Mol Biol. 1278, 183\u2013204 (2015).","DOI":"10.1007\/978-1-4939-2425-7_11"},{"key":"18174_CR19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","volume":"369","author":"Y Watanabe","year":"2020","unstructured":"Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science 369, 330\u2013333 (2020).","journal-title":"Science"},{"key":"18174_CR20","doi-asserted-by":"publisher","unstructured":"Woo, H. et al. Developing a fully glycosylated full-length SARS-CoV-2 spike protein model in a viral membrane [published online ahead of print, 2020 Jul 6]. J. Phys. Chem. B https:\/\/doi.org\/10.1021\/acs.jpcb.0c04553 (2020).","DOI":"10.1021\/acs.jpcb.0c04553"},{"key":"18174_CR21","doi-asserted-by":"publisher","unstructured":"Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Preprint. bioRxiv. Published 2020 May 29. https:\/\/doi.org\/10.1101\/2020.05.28.121533 (2020).","DOI":"10.1101\/2020.05.28.121533"},{"key":"18174_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans, S. Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem. 82, 775\u2013797 (2013).","journal-title":"Annu. Rev. Biochem."},{"key":"18174_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","volume":"181","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell 181, 1004\u20131015.e1015 (2020).","journal-title":"Cell"},{"key":"18174_CR24","doi-asserted-by":"publisher","unstructured":"Huo, J. et al. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 [published online ahead of print, 2020 Jul 13]. Nat Struct Mol Biol. https:\/\/doi.org\/10.1038\/s41594-020-0469-6 (2020).","DOI":"10.1038\/s41594-020-0469-6"},{"key":"18174_CR25","doi-asserted-by":"crossref","unstructured":"Chi, X. et al. Humanized single domain antibodies neutralize SARS-CoV-2 by targeting spike receptor binding domain. bioRxiv (2020).","DOI":"10.1101\/2020.04.14.042010"},{"key":"18174_CR26","doi-asserted-by":"crossref","unstructured":"Wu, Y. et al. Identification of human single-domain antibodies against SARS-CoV-2. Cell Host Microbe. 27, 891\u2013898.e5 (2020).","DOI":"10.1016\/j.chom.2020.04.023"},{"key":"18174_CR27","doi-asserted-by":"crossref","unstructured":"Walter J. D. et al. Sybodies targeting the SARS-CoV-2 receptor-binding domain. Preprint at 2020.2004.2016.045419 (2020).","DOI":"10.1101\/2020.04.16.045419"},{"key":"18174_CR28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil, V. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905\u2013913.e907 (2020).","journal-title":"Cell"},{"key":"18174_CR29","doi-asserted-by":"crossref","first-page":"15.13.11","DOI":"10.1002\/cpps.38","volume":"89","author":"JM Antos","year":"2017","unstructured":"Antos, J. M. et al. Site-specific protein labeling via sortase-mediated transpeptidation. Curr. Protoc. Protein Sci. 89, 15.13.11\u201315.13.19 (2017).","journal-title":"Curr. Protoc. Protein Sci."},{"key":"18174_CR30","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/nprot.2013.103","volume":"8","author":"MD Witte","year":"2013","unstructured":"Witte, M. D. et al. Production of unnaturally linked chimeric proteins using a combination of sortase-catalyzed transpeptidation and click chemistry. Nat. Protoc. 8, 1808\u20131819 (2013).","journal-title":"Nat. Protoc."},{"key":"18174_CR31","doi-asserted-by":"publisher","first-page":"e03239","DOI":"10.7554\/eLife.03239","volume":"3","author":"BA Sosa","year":"2014","unstructured":"Sosa, B. A. et al. How lamina-associated polypeptide 1 (LAP1) activates Torsin. Elife 3, e03239 (2014).","journal-title":"Elife"},{"key":"18174_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jim.2007.04.008","volume":"324","author":"DR Maass","year":"2007","unstructured":"Maass, D. R., Sepulveda, J., Pernthaner, A. & Shoemaker, C. B. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). J. Immunol. Methods 324, 13\u201325 (2007).","journal-title":"J. Immunol. Methods"},{"key":"18174_CR33","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1093\/bioinformatics\/btv401","volume":"31","author":"RC Edgar","year":"2015","unstructured":"Edgar, R. C. & Flyvbjerg, H. Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics 31, 3476\u20133482 (2015).","journal-title":"Bioinformatics"},{"key":"18174_CR34","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1093\/nar\/gkz657","volume":"47","author":"V Kumar","year":"2019","unstructured":"Kumar, V. et al. Long-read amplicon denoising. Nucleic Acids Res. 47, e104 (2019).","journal-title":"Nucleic Acids Res."},{"key":"18174_CR35","doi-asserted-by":"publisher","unstructured":"Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model [published online ahead of print, 2020 Jun 15]. Science. eabc7520 https:\/\/doi.org\/10.1126\/science.abc7520 (2020).","DOI":"10.1126\/science.abc7520"},{"key":"18174_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","volume":"409","author":"M Sarzotti-Kelsoe","year":"2014","unstructured":"Sarzotti-Kelsoe, M. et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods 409, 131\u2013146 (2014).","journal-title":"J. Immunol. Methods"},{"key":"18174_CR37","unstructured":"Team RC, other. R: A Language and Environment for Statistical Computing (Team RC, other, Vienna, 2013)."},{"key":"18174_CR38","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).","DOI":"10.1007\/978-3-319-24277-4"},{"key":"18174_CR39","doi-asserted-by":"publisher","unstructured":"Wickham, H. et al. Welcome to the tidyverse. Journal of Open Source Software. 4, 1686 https:\/\/doi.org\/10.21105\/joss.01686 (2019).","DOI":"10.21105\/joss.01686"},{"key":"18174_CR40","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s41592-019-0580-y","volume":"16","author":"D Tegunov","year":"2019","unstructured":"Tegunov, D. & Cramer, P. Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146\u20131152 (2019).","journal-title":"Nat. Methods"},{"key":"18174_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"18174_CR42","doi-asserted-by":"crossref","unstructured":"Ilca, S. L. et al. Localized reconstruction of subunits from electron cryomicroscopy images of macromolecular complexes. Nat. Commun. 6, 8843 (2015).","DOI":"10.1038\/ncomms9843"},{"key":"18174_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nsb939","volume":"10","author":"MC Morais","year":"2003","unstructured":"Morais, M. C. et al. Bacteriophage \u03c629 scaffolding protein gp7 before and after prohead assembly. Nat. Struct. Mol. Biol. 10, 572\u2013576 (2003).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"18174_CR44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"18174_CR45","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"18174_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep34303","volume":"6","author":"SO Dahms","year":"2016","unstructured":"Dahms, S. O. et al. The structure of a furin\u2013antibody complex explains non-competitive inhibition by steric exclusion of substrate conformers. Sci. Rep. 6, 34303 (2016).","journal-title":"Sci. Rep."},{"key":"18174_CR47","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894\u2013904.e899 (2020).","journal-title":"Cell"},{"key":"18174_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"18174_CR49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"18174_CR50","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1006\/abio.1998.2937","volume":"265","author":"DG Myszka","year":"1998","unstructured":"Myszka, D. G., Jonsen, M. D. & Graves, B. J. Equilibrium analysis of high affinity interactions using BIACORE. Anal. Biochem. 265, 326\u2013330 (1998).","journal-title":"Anal. Biochem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18174-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18174-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T19:32:51Z","timestamp":1670268771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18174-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18174"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18174-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.02.130161","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"19 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4420"}}